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Immunological diagnostic methods for Trypanosoma cruzi depend specifically on the presence of antibodies and 
parasitological methods lack sensitivity during the chronic and “indeterminate” stages of the disease. This study 
performed a serological survey of 1,033 subjects from 52 rural communities in 12 of the 18 municipalities in the state 
of Querétaro, Mexico. We detected anti-T. cruzi antibodies using the following tests: indirect haemagglutination as-
say (IHA), indirect immunofluorescence assay (IFA), ELISA and recombinant ELISA (rELISA). We also performed 
Western blot (WB) analysis using iron superoxide dismutase (FeSOD), a detoxifying enzyme excreted by the parasite, 
as the antigen. Positive test results were distributed as follows: ELISA 8%, rELISA 6.2%, IFA and IHA 5.4% in both 
cases and FeSOD 8%. A comparative study of the five tests was undertaken. Sensitivity levels, specificity, positive 
and negative predictive values, concordance percentage and kappa index were considered. Living with animals, 
trips to other communities, gender, age, type of housing and symptomatology at the time of the survey were statisti-
cally analysed using SPSS software v.11.5. Detection of the FeSOD enzyme that was secreted by the parasite and 
used as an antigenic fraction in WBs showed a 100% correlation with traditional ELISA tests.
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Chagas disease is a primary public health issue in 
Latin America. The World Health Organization (WHO) 
states that approximately eight million persons are infect-
ed in Latin America and an additional 20 million people 
are at risk of contracting the infection (Miles 2004).
The first methods that were used to identify Chagas 
disease included the complement fixation test, which 
was used by Guerrero and Machado in 1913, as well as 
the identification of unilateral conjunctivitis and Roma-
na’s sign (OMS 1991, OPS 1993, Miles 2004).
Historically, the possibility of transmission via blood 
transfusion was first described by Mazza et al. (1936), 
followed nine years later by Días (1945) in Brazil and by 
Bacigalupo (1945) in Argentina. Talice (1947) in Uru-
guay reported a related study.
Reactive blood donors were diagnosed for the first 
time in 1949 using the complement fixation test in Belo 
Horizonte (Pellegrino 1949) and São Paulo, Brazil (Faria 
1951, Freitas et al. 1952).
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Treatment of potentially infected donor blood using 
crystal violet dye was proposed at approximately the 
same time (Nussenzweig et al. 1953).
The risk of transmission of Chagas disease via blood 
transfusion is largely due to the following factors: (i) hun-
dreds of donors are infected, but asymptomatic and the 
stage or phase of the disease is not known, (ii) donors 
come from geographical areas in which Chagas disease is 
endemic (Guzmán-Bracho et al. 1998), (iii) serum-reac-
tive donors are not detected at blood banks, (iv) symptoms 
of the disease in its chronic phase are mistaken for less 
severe pathologies, (v) no serological analyses are per-
formed in urban areas or the analyses lack the appropri-
ate sensitivity and specificity, (vi) transmission can occur 
by other routes, such as organ transplants, bone marrow 
transplants, accidents in the clinical laboratory and orally, 
(vii) congenital transmission, (viii) frequent immigra-
tion of persons from endemic zones to regions where the 
vector insect is not present and (ix) lack of vector control 
strategies, adequate epidemiological data and awareness 
of Chagas disease as a public health issue (Castro 2009).
Control measures have been implemented during 
the last 20 years in Latin America, with a resulting drop 
in the prevalence of transmission by blood transfusions 
(Castro 2009).
During the acute phase of the disease, antibody iden-
tification is possible by the fourth week after infection. 
The minimum standard for establishing an acute phase 
diagnosis is the documentation of serum conversion 
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(from negative to positive) by conventional serological 
testing of two paired serum samples obtained less than 
one month apart. Parasitaemias are transitory during the 
chronic phase and parasite detection in blood is com-
pletely random with low sensitivity. The diagnosis is 
based on a finding of anti-Trypanosoma cruzi antibodies 
in the bloodstream (Lorca et al. 1990).
Conventional serological tests alone are not suf-
ficient, mainly because antigenic preparations are de-
rived from parasite extracts or semi-purified fractions of 
epimastigotes (the non-infectious form of the parasite) 
and procedures differ between laboratories. Therefore, 
inconclusive results are frequently obtained (Berriz-
beitia et al. 2012). However, some patients with Chagas 
disease have false negative results (Kirchhoff & Neva 
1985, Araújo & Berne 2013). The WHO recommends the 
use of three assays because of the aforementioned incon-
veniences and variations in the sensitivity of serologi-
cal screening in blood banks and individual diagnoses. 
ELISA, indirect haemagglutination assays (IHA) and 
recombinant (rELISA) or indirect immunofluorescence 
assays (IFA) are used for the diagnosis of Chagas disease 
(NOM 1999, Foti et al. 2009). An infected person with 
reactive serum must undergo at least two serological as-
says (Foti et al. 2009).
This practice is mandatory in Argentina and enforce-
ment began in Brazil in December 2002. Monteón-Padil-
la et al. (1999) demonstrated that the IHA technique has 
a very low sensitivity and is not a reliable test in blood 
donors. ELISA is therefore recommended for screening 
samples at blood banks; however, an ELISA test that 
employs recombinant antigens or synthetic peptides 
(Longhi et al. 2012) and demonstrates high sensitivity 
and specificity should be used (OMS 1990, 1991).
Similarly, an epidemiological profile for the studied 
communities must be designed to evaluate variables in 
the population under study, such as housing type, co-
habitation with animals, trips outside the communities 
of origin, symptomatology during the survey, age and 
age distribution and gender (OMS 1991). This informa-
tion will render an accurate profile of the rural localisa-
tion of this endemic disease, which is crucial for Mexico 
(Guzmán-Bracho 2001).
SUBJECTS, MATERIALS AND METHODS
Population studied - A total of 1,033 blood samples 
were drawn from subjects from 51 rural communities 
in 12 of the 18 municipalities in the state of Querétaro. 
Sampling was based on reports of an existing vector 
(Villagrán et al. 2008), housing conditions, co-habitation 
with animals and seropositivity (as reported by blood 
bank-based ELISA testing) (CETS 2002).
The sample size was calculated using the statistical 
program Epi Info v.2002. Statistical analyses of frequen-
cies and statistical significance were performed using 
SPSS 11.5 software.
The Committee of Bioethics and Research of the 
University of Granada, Spain approved this study.
Blood sampling - Blood samples were drawn during 
the epidemiological interview from the cubital vein of 
either the right or left forearm after the area was disin-
fected and cleaned using a cotton pellet soaked with a 
mixture of 5% glycerol in ethanol. Blood samples were 
collected in glass vacuum containers (7 mL) containing 
gel that inhibited blood clotting and prevented haemoly-
sis. This precaution was important because samples were 
frequently moved during transportation to the laboratory. 
Blood was centrifuged at 5,000 rpm for 10 min to sepa-
rate serum from the globular fraction. Serum was stored 
in five 50-µL aliquots and frozen at -20ºC until used.
Serological assays - Determination of antibody ex-
pression in the 1,033 serum samples was performed us-
ing conventional assays. Total extracts of the epimastig-
ote forms of T. cruzi (BioMérieux®) were used for ELISA 
testing and cut-off points were established for each se-
ries of sera studied (Lorca et al. 1990). rELISA (Wiener 
lab®) employed six antigens synthesised from trypomas-
tigote and epimastigote fragments from various T. cruzi 
strains (SAPA, 1, 2, 13, 30 and 36) (Longhi et al. 2012). 
Reactivity at dilutions > 1:8 was considered positive for 
IHA (Wiener lab®). The Camargo method was employed 
for IFA, using complete forms of T. cruzi epimastigotes 
isolated from strain Y (of Brazilian origin) and strain T3 
(of Mexican origin, state of Veracruz, derived from in 
vitro cultures in Grace medium). Samples with titres > 
1:16 were considered positive (Camargo et al. 1986, Ber-
rizbeitia et al. 2012).
New diagnostic techniques - The iron superoxide 
dismutase (FeSOD) method uses the isoenzyme FeSOD 
as an immunogenic protein for T. cruzi. This protein 
is extracted from the epimastigote and trypomastigote 
forms, which were isolated from the Colombian strain 
and cultured in vitro in Grace medium (Sigma®) supple-
mented with 10% bovine foetal serum (v/v) (Gibco®) that 
had been previously heat inactivated at 56ºC for 30 min. 
Flagellates were cultivated in 3 mL of medium in 25-cm2 
plastic Roux flasks (Corning) at 28ºC at an initial con-
centration of 5 x 104 cells/mL. Cultures were centrifuged 
at 1,500 rpm for 10 min when the cellular concentration 
reached approximately 2 x 107 cells/mL (counted in a 
Neubauer haemocytometer chamber). The resulting pel-
let was rinsed twice in phosphate-buffered saline and 
centrifuged. The extracted enzyme was purified, frac-
tioned and used as an antigen in Western blots to de-
tect anti-T. cruzi antibodies in the 1,033 serum samples. 
The test was considered to be positive when anti-T. cruzi 
antibodies were detected at a dilution of 1:80 (Marín & 
Sánchez-Moreno 2010, Berrizbeitia et al. 2012). Evalua-
tions of statistically significant differences between the 
tests were based on sensitivity, specificity, negative and 
positive predictive values, concordance percentage and 
the kappa index. The following epidemiological vari-
ables were considered in this study: presence of the vec-
tors Triatoma mexicana (94%), Triatoma dimidiate (3%), 
Triatoma gerstaeckeri (2%) and Triatoma pallidipennis 
(1%) (Villagrán et al. 2009), gender, age, housing type, 
co-habitation with animals, trips outside the commu-
nity and reported symptomatology that was compatible 
with known signs and symptoms of the acute or chronic 
phases of Chagas disease. Comparisons between epide-
miologic parameters and survival patterns were estab-
lished in every studied population (Ferrer et al. 2013). 
Statistical analyses were performed using SPSS v.11.5 to 
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measure confidence values and statistical significance 
between parameters.
These data were collected using an epidemiological 
survey, which was completed at the time of blood sample 
collection.
RESULTS AND DISCUSSION
The five immunological tests were performed in 
1,033 samples and yielded the following percentages of 
positive findings: ELISA 8%, rELISA 6.2% and IHA 
and IFA 5.4%. The 8% positive rate for FeSOD testing 
was consistent with the results of the most commonly 
used antibody test (Fig. 1, Table I).
All serological techniques are used primarily dur-
ing the latent and chronic stages of infection, when it 
is difficult to identify the parasites. Cross-reactivity of 
Chagas disease tests with circulating antibodies related 
to other infections and diseases, such as leishmaniasis, 
malaria, toxoplasmosis, hepatitis, leprosy, syphilis and 
Fig. 1: immunological tests applied to samples of the studied individu-
als in rural communities in the state of Querétaro, Mexico. FeSOD: iron 
superoxide dismutase; IFA: indirect immunofluorescence assay; IHA: 
indirect haemagglutination assay; rELISA: recombinant ELISA. 
TABLE I








(n)ELISA rELISA IHA IFA FeSOD
Santiago de Querétaro Rancho el Pitayo 1 1 1 1 1 1 31
Arroyo Seco Tanchanaquito 1 1 0 0 1 1 22
El Rejalgar 1 1 0 0 1 1
Pinal de Amoles Las Adjuntas 2 0 2 2 2 2 60
Barranca del Plátano 2 1 1 1 2 2
El Plátano 1 1 1 1 1 1
Landa de Matamoros La Aguita 3 1 1 1 3 3 3
Peñamiller Alamitos 3 2 2 2 3 3 87
El Pilón 4 2 3 3 4 4
Cadereyta Boyecito 8 5 3 3 7 8 218
Llanitos 7 4 3 3 7 7
Tolimán Panales 2 2 2 2 2 2 290
San Pablo 4 2 2 2 4 4
Horno de Cal 2 1 2 2 2 2
Colón El Gallo 11 9 11 11 11 11 122
Viborillas 1 1 0 0 1 1
El Marqués San Vicente Ferrer 9 5 4 4 9 9 109
Atongo 2 2 3 3 2 2
Tierra Blanca 2 1 0 0 2 2
Huimilpan Guadalupe 1 1 0 0 0 1 1 27
Las taponas 1 1 1 1 1 1
Santa Teresa 1 1 1 1 1 1
San Juan del Río San Juan del Río 9 6 10 10 9 9 49
Corregidora Alfayúcan 1 1 1 1 1 1 15
Joaquín Herrera 1 1 0 0 1 1
Total - 80 62 54 54 80 80 1,033
new diagnostic tool is considered, the iron superoxide dismutase (FeSOD). IFA: indirect immunofluorescence assay; IHA: indi-
rect haemagglutination assay; rELISA: recombinant ELISA.
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collagen vascular diseases, is common (Carvalho et al. 
1993, Bottino et al. 2013, Guevara et al. 2013). This cross-
reactivity inspired us to conduct a study of five different 
serologic tests to determine the statistical concordance 
among these tests and identify the true seroprevalence 
rate, as has been previously described by the WHO (Foti 
et al. 2009). The results are shown in Table II.
The statistical correlation rates between the five im-
munological tests were 8% between ELISA and FeSOD, 
6.2% between ELISA and rELISA and 5.4% between 
IHA and ELISA-ELISA-IFA, showing that the sensitiv-
ity and specificity varied considerably. However, this 
variability can be attributed to technical problems. For 
example, recent recommendations suggest the use of 
fresh sera and avoiding freezing and thawing samples 
that will be used for rELISA because sensitivity with re-
spect to IHA is lost. IHA does not work with antigenic 
extracts of T. cruzi strains that are obtained from hu-
mans; this test uses sensitised erythrocytes from sheep 
blood with antigenic extracts of the epimastigote forms 
of cultured T. cruzi, which reduces sensitivity and speci-
TABLE II
Statistical correlation between the five immunological tests used in the study with the enzyme  














ELISA r-ELISA 75.6 99.9 98.5 98 98 0.8
ELISA-IFA 68.2 99.9 98.3 97 97 0.8
ELISA-IHA 63.5 100 100 97 97 0.8
ELISA-FeSOD 94.4 100 98.4 98 100 0.96
IFA: indirect immunofluorescence assay; IHA: indirect haemagglutination assay; NPV: negative predictive values; PPV: positive 
predictive values; rELISA: recombinant ELISA.
Fig. 2: prevalence of Trypanosoma cruzi seropositivity according 
to age group. FeSOD: iron superoxide dismutase; IFA: indirect im-
munofluorescence assay; IHA: indirect haemagglutination assay; 
rELISA: recombinant ELISA. 
Fig. 3: percentages of age groups in the studied population.
ficity. The predictive values and kappa index confirmed 
the usefulness of performing two immunological tests 
for the detection of possible infections with this haemo-
flagellate parasite.
Seroprevalence according to age showed that sero-
positivity decreases in increments as age increases. The 
survey also showed that infection is often present at a 
very young age, which implies the establishment of the 
vector in the risk zone (Fig. 2).
A total of 8.8% of seroreactive inhabitants were of 
reproductive age and they performed various activities. 
Therefore, a socio-economic problem arises when these 
inhabitants become infected because they are part of the 
economic support of their families. Most of the subjects in 
this study were women (74%) and only 26% were men.
The majority of individuals sampled in this study 
(83.3%) were between the ages of 16-50 years old. This 
population often moves to other areas for work, study or 
leisure and they are considered high risk. Subjects be-
tween one-15 years of age made up 15.2% of the sample 
and subjects between 51-95 years old constituted 1.5% of 
the sample (Fig. 3).
Most of the population (99.3%) did not travel outside 
their communities and remained in the same locality 
for their entire lives. Additionally, the majority of the 
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population (98%) cohabited with animals and 8.7% had 
symptoms of infection, according to the survey that was 
performed at the beginning of the study.
The type of housing played an important role in the 
epidemiology of the infection because building materials 
constitute an important variable in the establishment of 
the vector. Details regarding the housing type are sum-
marised in Table III.
The only statistically significant difference noted in 
this study was in the percentage of the different tests that 
were reactive, relative to symptomatology (Fig. 4).
The Official Mexican Norm (NOM 1999) regarding 
blood testing for Chagas disease (NOM-033.SSA1-1997) 
mentions only that assays must be performed in cities 
in geographical areas where Chagas is endemic. The re-
sults obtained between ELISA-FeSOD was 8%, which 
indicates that infection by T. cruzi in Querétaro is five 
times higher than the national average of 1.6% (Guzmán-
Bracho 2001). The 8% seropositivity rate means that 84 
Fig. 4: percentage of reactive cases in the relation to the different 
assays. FeSOD: iron superoxide dismutase; IFA: indirect immuno-
fluorescence assay; IHA: indirect haemagglutination assay; rELISA: 
recombinant ELISA.
TABLE III
Percentage of the types of material that forms part of ceilings, walls, fences and floors  




















Roof 70 70 70 20 - - - 10 -
Wall 88 - 15 15 10 10 - - 90
Ground 50 - - - - - 50 60 50
individuals are reactive. If this rate is extrapolated to the 
entire population, an estimated 40,000 persons are in-
fected, 30% of whom will develop cardiac disease in the 
next 15-20 years. It is important to mention that Queré-
taro should be considered an endemic area because our 
results reflect a high percentage of high-risk individuals 
and there is active transmission of infection (15.2% age 
paediatric). The results have been reported to the Health 
Services of the State of Querétaro. We were also able to 
establish ELISA as the test of choice for the detection of 
anti-T. cruzi antibodies for all persons who donate blood 
at the State Centre of Haemotherapy. Testing for T. cruzi 
should not be reserved for individuals from endemic ar-
eas, despite possible controversy.
Similarly, the results obtained with ELISA and FeSOD 
testing, which are sensitive and specific for genus and spe-
cies, found that the use of an enzyme-extracted parasite as 
the antigen (instead of antigenic extracts of epimastigote 
forms and/or trypomastigotes) cross-reacted with other 
aetiological agents; this technique should therefore be 
avoided because of the risk of false positive findings.
New diagnostic techniques, such as the superoxide 
dismutase technique, have been designed as confirma-
tory tests to overcome this problem. The superoxide dis-
mutase assay is the only diagnostic approach that can 
identify anti-T. cruzi antibodies (Villagrán et al. 2005). 
It should be used in blood banks as the only definitive 
diagnostic test for the detection and confirmation of re-
active Chagas infection and can eliminate the need to 
perform second and third tests for the disease (Wendel 
& Leiby 2007, Villagrán et al. 2009).
The collected data show active transmission of T. 
cruzi in Querétaro, which was not previously considered 
an endemic zone.
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